SRF-28063-23752
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 26-30
- ZIP prefix
- 853 / AZ
- Registered
- 2021-01-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-23
Registered in v-safe
-
2021-01-23
Dose 1 — Pfizer-BioNTech
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-29
- 2021-01-30
- 2021-02-07
-
2021-02-13
Dose 2 — Pfizer-BioNTech
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
-
2021-03-08
Survey response — day 21, dose 2MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold-like symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-20
- 2021-03-27
-
2021-05-15
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold-likeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-14
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Cold-like symptomsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-13
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
-
2022-02-16
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-23 | Pfizer-BioNTech | |
| 2 | 2021-02-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-13 | Successful 2022-02-16 |
Does not wish to fill out VAERS report |
Free text
Release 5 — day 21, dose 2
Symptoms: Cold-like symptoms
Release 8 — 3 months, dose 2
Symptoms: Cold-like
Release 9 — 6 months, dose 2
Symptoms: Cold-like symptoms
Release 11 — 12 months, dose 2
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release